NFKB1 −94ins/delATTG polymorphism is a novel prognostic marker in first line‐treated multiple myeloma

E-ISSN： 1365-2141|168|5|679-688

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.168, Iss.5, 2015-03, pp. : 679-688

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Functional Insertion/Deletion Polymorphism (-94 ins/del ATTG) in the Promoter Region of the NFKB1 Gene Is Related to the Risk of Renal Cell Carcinoma

Urologia Internationalis, Vol. 91, Iss. 2, 2012-12 ,pp. : 206-212

Karger

Access to resources Recommend Favorite

Microvessel Density as a Surrogate Prognostic Marker in Patients with Multiple Myeloma: A Meta-Analysis

Acta Haematologica, Vol. 138, Iss. 2, 2017-08 ,pp. : 77-84

Karger

Access to resources Recommend Favorite

Circulating plasma cells in newly diagnosed symptomatic multiple myeloma as a possible prognostic marker for patients with standard‐risk cytogenetics

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 4, 2015-08 ,pp. : 523-531

John Wiley & Sons Inc

Access to resources Recommend Favorite

Syndecan-1 Expression – A Novel Prognostic Marker in Pancreatic Cancer

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 97-106

Karger

Access to resources Recommend Favorite

MDR1 C3435T Polymorphism Indicates a Different Outcome in Advanced Multiple Myeloma

Acta Haematologica, Vol. 122, Iss. 1, 2009-08 ,pp. : 42-45

Karger

Access to resources Recommend Favorite